McKinsey Quoted $200K. I Have $15K and 6 Weeks.

The Board Meeting That Changed Everything

The board meeting was supposed to be routine. Eighteen months post-Series A, the SaaS company had $3.2M ARR and was growing at 40% year-over-year. Product-market fit was real. The engineering team was executing. Customers were renewing.

Then the lead investor asked a question: "Walk me through your go-to-market strategy for the next 18 months."

The founder pulled up a slide deck. TAM: $12 billion. Growth rate: "strong." Competitive positioning: a 2x2 matrix with the company in the upper-right quadrant. Pricing: three tiers based on what "felt right" after looking at competitor pricing pages.

The board's response was polite but unambiguous: "This isn't a strategy. This is a set of assumptions. We need institutional-quality market intelligence before we commit to the next tranche."

The founder left the meeting with a mandate and a deadline: deliver a defensible GTM plan within 6 weeks, before the next board meeting.

The $200K Wall

The founder did what most Series A CEOs do — he called McKinsey.

The proposal came back in 48 hours: $200,000 to $350,000 for a comprehensive go-to-market strategy engagement. Timeline: 12 to 16 weeks. A team of 3-4 consultants would conduct market sizing, competitive analysis, pricing optimization, and sales process design.

The deliverables would be world-class. McKinsey's methodology is proven across thousands of engagements. The evidence standard would survive any board scrutiny.

But the economics were impossible.

The company had $4.1M in the bank. Burning $85K per month. Runway of 48 months at current burn — but only if growth continued. Spending $200K-$350K on consulting would consume 5-8% of total capital. And the 12-16 week timeline meant the results would arrive after the board meeting, not before it.

McKinsey wasn't wrong about the price. That's what institutional-quality consulting costs when delivered by teams of highly credentialed analysts working out of Manhattan and Toronto offices. The problem wasn't McKinsey's pricing — it was the structural mismatch between institutional consulting economics and growth-stage company economics.

The Other Side: Free Isn't Free Either

The founder's next instinct was to do it himself. He had ChatGPT. He had Claude. He could generate a market analysis in an afternoon.

He tried. The output looked professional. The formatting was clean. The narrative was compelling.

Then he started checking the numbers.

The "market size" figure cited a report that didn't exist. The "competitive analysis" included a company that had been acquired two years earlier. The "pricing benchmark" was fabricated — the AI had generated plausible-sounding numbers that matched no real-world data source.

This is the trap. AI tools produce strategy-shaped content at near-zero cost. But strategy-shaped content without evidence is worse than no strategy at all — because it creates false confidence that collapses under scrutiny.

The Evidence Gap

The founder's situation illustrates what we call the Evidence Gap: the space between institutional-quality strategic analysis and growth-stage economic constraints.

On one side: McKinsey, BCG, Bain, Deloitte. Methodologically rigorous. Evidence-based. Defensible. $200K+ and 12-16 weeks.

On the other side: AI tools, freelance consultants, founder-built analysis. Fast and affordable. Unverifiable. Indefensible under scrutiny.

The gap between these two options is where most growth-stage companies live. They can't afford institutional quality, and they can't risk institutional embarrassment. So they operate in a strategic grey zone — presenting numbers they haven't verified, citing sources they haven't checked, and hoping nobody asks the hard questions.

The U.S. management consulting market generated $470.3 billion in 2025 (Industry Research, 2025). The market has over 5 million firms, and no single firm holds more than 1% market share. Yet the pricing structure of the top firms has barely changed in decades. The Big 4 and MBB firms are optimized for Fortune 500 engagements — not for a Series A company with $15K and a board deadline.

Bridging the Gap

The structural question is: can you deliver institutional evidence quality at growth-stage economics?

The answer is yes — but not with the traditional consulting model. The traditional model relies on bespoke research by expensive analysts billing at $300-$600 per hour. Every engagement starts from scratch. Every deliverable is hand-crafted. That's why it costs $200K.

A different model is possible when you invert the approach:

Instead of starting from scratch, start from a curated knowledge base. Sagentix operates on a foundation of 549+ curated consulting artifacts — 54 proprietary frameworks, 136 peer-reviewed research briefs, 66 industry research briefs, and 194 evidence tables. Every phase of the engagement draws on pre-validated, source-cited research rather than generating analysis from nothing.

Instead of a 12-16 week timeline, run a 10-phase pipeline in 6-8 weeks. Market Intelligence, Value Proposition Design, Messaging, Pitch Deck, Sales Process, Pricing, Business Model, Strategy Execution, Digital Audit, and Evidence Discipline — delivered sequentially with automated quality gates between each phase.

Instead of $200K-$350K, price at $12,000-$50,000. The knowledge base and automation eliminate the massive analyst-hour overhead that drives Big 4 pricing. The evidence standard stays the same. The economics change dramatically.

What the Founder Got

The founder engaged Sagentix for the full 10-phase GTM engagement. Here's what he had before his next board meeting:

• Bottom-up TAM build with premium industry research data, APA 7th citations, and page-level provenance on every market figure
• Competitive positioning matrix based on verified competitor data, not opinions
• Value-based pricing model with three tiers, willingness-to-pay analysis, and margin projections
• Documented sales process with stage definitions, conversion benchmarks, and pipeline metrics
• Board-ready deliverables — each passing 6 quality checks, each with every claim sourced and every number verifiable

The board meeting went differently this time. When the lead investor asked "where did these numbers come from?" — the founder had the answer. Every citation. Every source. Every methodology note.

The board approved the next tranche.

The Decision Framework

If you're a growth-stage founder facing the Evidence Gap, here's the framework:

1. If you have $200K+ and 16 weeks — hire McKinsey or BCG. They're excellent. Their methodology is proven over decades. The premium is worth it if you can afford it.
2. If you have $12K-$50K and 6-8 weeks — this is the space Sagentix was built for. Institutional evidence quality. Growth-stage economics. Every claim sourced. Every deliverable defensible.
3. If you have $0 and 2 days — use AI tools for internal exploration, but never present the output externally without independent verification. Label everything as preliminary.

The one option that doesn't work is the grey zone: spending $5K-$15K on analysis that looks professional but can't survive the question "where did you get that number?"

The Real Cost of the Evidence Gap

The founder's story has a coda. After the board meeting, he ran the numbers on what the Evidence Gap had cost him before he closed it:

• Two lost enterprise deals where the prospect asked for market validation during the sales process and the founder couldn't provide it
• A pricing structure that left an estimated 20-30% of value on the table because it was set by competitor benchmarking, not value analysis
• Four months of misallocated sales effort targeting a vertical that the market data would have deprioritized

The $200K McKinsey quote would have been a good investment. The $15K Sagentix engagement was a better one — not because it was cheaper, but because it arrived in time.

The Evidence Gap doesn't just cost money. It costs time, deals, and board confidence. The question isn't whether you can afford to close it — it's whether you can afford not to.